Research & Innovation
Publications
Durvalumab Prolongs Overall Survival, Whereas Radiation Dose Escalation > 66 Gy Might Improve Long-Term Local Control in Unresectable NSCLC Stage III: Updated Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)
PMU Authors
Franz Zehentmayr, Elvis Ruznic, Brane Grambozov, Alexandra Hochreiter, Falk Röder
All Authors
Franz Zehentmayr, Elvis Ruznic, Petra Feurstein, Brigitte Langer, Brane Grambozov, Marisa Klebermass, Alexandra Hochreiter, Ayurzana Purevdorj, Georg Gruber, Danijela Minasch, Barbara Böhmer-Breitfelder, Claudia Steffal, Karoline Kirchhammer, Heidi Stranzl, Falk Röder, Karin Dieckmann
Journal association
Cancers